Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graziano Caltabiano

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Treatment Reviews|January 25, 2012
Uveal melanomaFrancesco Spagnolo, Graziano Caltabiano, Paola Queirolo
Japanese Journal of Clinical Oncology|September 17, 2013
CA125-related measures of tumor kinetics and outcome of patients with recurrent ovarian cancer receiving chemotherapy: a retrospective evaluationGiuseppe Colloca, Antonella Venturino, Gianfranco Addamo, et al.
Urologic Oncology|November 19, 2013
Prostate-specific antigen growth rate constant after first-line cytotoxic chemotherapy in metastatic castration-resistant prostate cancer: a monoinstitutional experienceGiuseppe Colloca, Antonella Venturino, Gianfranco Addamo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2011
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimensDavide Bedognetti, Gabriele Zoppoli, Carlotta Massucco, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Treatment Reviews|January 25, 2012
Uveal melanomaFrancesco Spagnolo, Graziano Caltabiano, Paola Queirolo
Japanese Journal of Clinical Oncology|September 17, 2013
CA125-related measures of tumor kinetics and outcome of patients with recurrent ovarian cancer receiving chemotherapy: a retrospective evaluationGiuseppe Colloca, Antonella Venturino, Gianfranco Addamo, et al.
Urologic Oncology|November 19, 2013
Prostate-specific antigen growth rate constant after first-line cytotoxic chemotherapy in metastatic castration-resistant prostate cancer: a monoinstitutional experienceGiuseppe Colloca, Antonella Venturino, Gianfranco Addamo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2011
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimensDavide Bedognetti, Gabriele Zoppoli, Carlotta Massucco, et al.
Pageof 1